Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07740499
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel DiseaseIRCCS San RaffaeleNot Yet Recruiting
NCT07740499Not Yet Recruiting
—
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammator...IRCCS San Raffaele
NCT07738939
IKS04 Regimen in Advanced Solid Tumors That Express CA242Iksuda Therapeutics Ltd.Not Yet RecruitingPhase 1
NCT07738939Not Yet Recruiting
Phase 1
IKS04 Regimen in Advanced Solid Tumors That Express CA242Iksuda Therapeutics Ltd.
NCT07739186
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739186Not Yet Recruiting
Phase 2
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody...Baili-Bio (Chengdu) Pharm...
NCT07740122
AI-Based Stool Image Analysis for Colorectal Neoplasia Risk AssessmentServicio de Salud Metropolitano Sur OrienteRecruiting
NCT07740122Recruiting
—
AI-Based Stool Image Analysis for Colorectal Neoplasia Risk AssessmentServicio de Salud Metropo...
NCT07738380
Robot-Assisted Closed Reduction and Internal Fixation for Femoral Shaft FracturesAerospace Center HospitalRecruitingNot Applicable
NCT07738380Recruiting
Not Applicable
Robot-Assisted Closed Reduction and Internal Fixation for Femoral Shaft Fracture...Aerospace Center Hospital
NCT07738679
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not Yet RecruitingPhase 2
NCT07738679Not Yet Recruiting
Phase 2
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Particip...Chia Tai Tianqing Pharmac...
NCT07738887
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 AlterationsAbbVieNot Yet RecruitingPhase 2
NCT07738887Not Yet Recruiting
Phase 2
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic...AbbVie
NCT07739173
Multicomponent Versus Balance Exercise for Older Adults With Recurrent FallsBalikesir UniversityCompletedNot Applicable
NCT07739173Completed
Not Applicable
Multicomponent Versus Balance Exercise for Older Adults With Recurrent FallsBalikesir University
NCT07740564
Phase III Study of OT202 in Treating Moderate to Severe Dry EyeOcumension Therapeutics (Suzhou) Co., LtdNot Yet RecruitingPhase 3
NCT07740564Not Yet Recruiting
Phase 3
Phase III Study of OT202 in Treating Moderate to Severe Dry EyeOcumension Therapeutics (...
NCT07739992
Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord InjuryMilap SandhuRecruitingNot Applicable
NCT07739992Recruiting
Not Applicable
Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord InjuryMilap Sandhu
NCT07739264
ZEPU-SGI1PLUS Hand Training Study (ZEPUSGI1RCT)Bangladesh Medical UniversityNot Yet RecruitingNot Applicable
NCT07739264Not Yet Recruiting
Not Applicable
ZEPU-SGI1PLUS Hand Training Study (ZEPUSGI1RCT)Bangladesh Medical Univer...
NCT07740421
A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Efficacy of NH002 as a Contrast Agent Administrated Via Intravenous Bolus Injection and Infusion for Subjects Undergoing Cardiac EchocardiographySyneos HealthNot Yet RecruitingPhase 3
NCT07740421Not Yet Recruiting
Phase 3
A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Effi...Syneos Health
NCT07738237
Clinical Evaluation of Hearing Aid OTC Self-Assessment Methods for Adults With Perceived Mild-to-Moderate Hearing LossGlobal Edge Medtech ConsultingNot Yet RecruitingNot Applicable
NCT07738237Not Yet Recruiting
Not Applicable
Clinical Evaluation of Hearing Aid OTC Self-Assessment Methods for Adults With P...Global Edge Medtech Consu...
NCT07739290
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney InjuryBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07739290Not Yet Recruiting
Not Applicable
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute...Beth Israel Deaconess Med...
NCT07738159
Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine CarcinomaWest China HospitalNot Yet RecruitingPhase 2
NCT07738159Not Yet Recruiting
Phase 2
Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extra...West China Hospital
NCT07738315
Elemene Liposomes in Endometrial CancerBeijing Friendship HospitalNot Yet RecruitingPhase 2
NCT07738315Not Yet Recruiting
Phase 2
Elemene Liposomes in Endometrial CancerBeijing Friendship Hospit...
NCT07739017
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals, Inc.Not Yet RecruitingPhase 1
NCT07739017Not Yet Recruiting
Phase 1
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaCurtana Pharmaceuticals,...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07740551
Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy ControlsIzmir Democracy UniversityNot Yet Recruiting
NCT07740551Not Yet Recruiting
—
Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy ControlsIzmir Democracy Universit...
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Phase 25 (25%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 32 (10%)